Pharma Marketing News Vol. 10, No. 3: 17 FEBRUARY 2011
Welcome to Volume 10, Issue #3 (17 FEBRUARY 2011) of Pharma Marketing News.
Pharma Marketing News Vol. 10, No. 1: JANUARY 12, 2011
Welcome to Volume 10, Issue #1 (JANUARY 12, 2011) of Pharma Marketing News.
Boehringer vs Facebook Social Media Socialism
Boehringer-Ingelheim (BI) stands out in its attempt to stand out from the social(ist) cookie-cutter crowd of pharma FB pages. Shows what you can do with dedicated resources and creativity.
AstraZeneca Hosts First-Ever Twitter Chat
Despite dire predictions of 'PR failure,' the #rxsave Twitter chat hosted by @AstraZenecaUS on 15 February 2011 was a great success, which is pharma social media speak for 'did not crash and burn.' It was proof that a pharmaceutical company can indeed host meaningful Twitter chats.
HCP Marketing Beyond the Physician
NPs, PAs, and even RNs are for the most part overlooked by the pharmaceutical industry, according to David Mittman, PA, president of Clinician 1. This article reviews the issue and includes tips for marketing to NPs and PAs.
The Big C in the Big Apple
HepC.tv is featuring the video 'Man-on-the-Street: New Yorkers' Reactions to the Big Yellow C.' Is it effective? How do we know?
Pharma Facebook Pages Being Phased Out: A Good Run While It Lasted!
No doubt you've heard that as of August 15, 2011, Facebook opened up comments on ALL pharma pages with some exceptions. That means that the pharmaceutical industry will no longer be able to shut off comments on their Facebook pages.
Four Useful Lessons Pharma Can Learn from the Pfizer Facebook Hack
Pfizer's US corporate Facebook page was hacked by some 'Kiddies.' What should the industry learn from this experience?
Certain Physician-Drug Industry Relationships Have Declined Dramatically
The authors of a physician survey published in the November 8, 2010, issue of Archives of Internal Medicine conclude 'given that 83.8% of physicians have PIRs, it is clear that industry still has substantial financial links with the nation's physicians. These findings support the ongoing need for a national system of disclosure of PIRs [Physician-Drug Industry Relationships].' Such a system is part of the Physician Sunshine Law, which is scheduled to go into effect in 2012 with public disclosure of payments scheduled to begin September, 2013.
Pharma TeleWeb e-Detailing
This article summarizes Eli Lilly's European experience using TeleWeb e-detailing, which combines a personal sales rep phone call with Web site surfing.
